Literature DB >> 21192930

Atorvastatin and Aβ(1-40): not as simple as cholesterol reduction in brain and relevance to Alzheimer disease.

D Allan Butterfield1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21192930     DOI: 10.1016/j.expneurol.2010.12.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  5 in total

Review 1.  Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration.

Authors:  Jeriel T R Keeney; Aaron M Swomley; Sarah Förster; Jessica L Harris; Rukhsana Sultana; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

2.  Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.

Authors:  D Allan Butterfield; Eugenio Barone; Cesare Mancuso
Journal:  Pharmacol Res       Date:  2011-04-22       Impact factor: 7.658

Review 3.  Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.

Authors:  Eugenio Barone; Fabio Di Domenico; D Allan Butterfield
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

Review 4.  Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.

Authors:  Edith Hamel; Jessika Royea; Brice Ongali; Xin-Kang Tong
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

5.  Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.

Authors:  Dongsheng Zhou; Huaxia Liu; Chenli Li; Fangyan Wang; Yaosheng Shi; Lingjiang Liu; Xin Zhao; Aiming Liu; Junfang Zhang; Chuang Wang; Zhongming Chen
Journal:  Metab Brain Dis       Date:  2016-02-16       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.